Connection

Michael Gold to Risk Factors

Back to Details
This is a "connection" page, showing publications Michael Gold has written about Risk Factors.
Michael Gold
Connection Strength
1.102
Risk Factors
  1. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study. Heart Rhythm. 2020 09; 17(9):1566-1574.
    View in: PubMed
    Score: 0.085
  2. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis. J Cardiovasc Electrophysiol. 2018 04; 29(4):609-615.
    View in: PubMed
    Score: 0.073
  3. Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two? Circulation. 2018 01 16; 137(3):217-218.
    View in: PubMed
    Score: 0.072
  4. Impact of Renal Function on Survival After Cardiac Resynchronization Therapy. Am J Cardiol. 2017 Jul 15; 120(2):262-266.
    View in: PubMed
    Score: 0.069
  5. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
    View in: PubMed
    Score: 0.065
  6. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion. J Cardiovasc Transl Res. 2013 Aug; 6(4):528-35.
    View in: PubMed
    Score: 0.053
  7. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial. J Cardiovasc Electrophysiol. 2012 Dec; 23(12):1317-25.
    View in: PubMed
    Score: 0.050
  8. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012 Jun 01; 5(3):468-74.
    View in: PubMed
    Score: 0.049
  9. Dynamic changes of T-wave alternans: does it predict short-term arrhythmia vulnerability? J Cardiovasc Electrophysiol. 2007 May; 18(5):518-9.
    View in: PubMed
    Score: 0.034
  10. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol. 2004 Feb; 15(2):170-6.
    View in: PubMed
    Score: 0.028
  11. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2003 Jan; 18(1):1-5.
    View in: PubMed
    Score: 0.026
  12. Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke. Europace. 2022 07 21; 24(7):1058-1064.
    View in: PubMed
    Score: 0.025
  13. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol. 2002 Apr; 25(4 Pt 1):408-13.
    View in: PubMed
    Score: 0.024
  14. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2002 Jan; 17(1):1-5.
    View in: PubMed
    Score: 0.024
  15. Using the years-of-healthy-life measure to calculate QALYs. Am J Prev Med. 2001 Jan; 20(1):35-9.
    View in: PubMed
    Score: 0.022
  16. Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation: Insights From ASSERT. Circ Arrhythm Electrophysiol. 2020 09; 13(9):e008655.
    View in: PubMed
    Score: 0.022
  17. Real-world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography. J Cardiovasc Electrophysiol. 2020 02; 31(2):417-422.
    View in: PubMed
    Score: 0.021
  18. Left ventricular endocardial pacing: don't try this at home. Pacing Clin Electrophysiol. 1999 Nov; 22(11):1567-9.
    View in: PubMed
    Score: 0.021
  19. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
    View in: PubMed
    Score: 0.019
  20. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk?of Heart Failure. J Am Coll Cardiol. 2018 06 12; 71(23):2603-2611.
    View in: PubMed
    Score: 0.019
  21. Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded Study. Dermatol Surg. 2018 06; 44(6):833-840.
    View in: PubMed
    Score: 0.019
  22. Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). Am Heart J. 2018 07; 201:160-163.
    View in: PubMed
    Score: 0.018
  23. Implications and treatment of atrial fibrillation after cardiothoracic surgery. Curr Opin Cardiol. 1998 Jan; 13(1):20-7.
    View in: PubMed
    Score: 0.018
  24. Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials. Circ Heart Fail. 2017 Oct; 10(10).
    View in: PubMed
    Score: 0.018
  25. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017 May 01; 38(17):1339-1344.
    View in: PubMed
    Score: 0.017
  26. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol. 1997 Jan 15; 79(2):150-3.
    View in: PubMed
    Score: 0.017
  27. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment. Circ Cardiovasc Imaging. 2016 May; 9(5).
    View in: PubMed
    Score: 0.016
  28. Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: a randomized controlled trial. Allergy. 2016 05; 71(5):701-10.
    View in: PubMed
    Score: 0.016
  29. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE). J Am Heart Assoc. 2015 Sep 11; 4(9):e002054.
    View in: PubMed
    Score: 0.015
  30. Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine. 2015 Mar 10; 33(11):1412-7.
    View in: PubMed
    Score: 0.015
  31. Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza Other Respir Viruses. 2014 Nov; 8(6):636-45.
    View in: PubMed
    Score: 0.014
  32. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014 May 27; 129(21):2094-9.
    View in: PubMed
    Score: 0.014
  33. Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol. 2013 Apr; 24(4):381-7.
    View in: PubMed
    Score: 0.013
  34. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study. Eur J Heart Fail. 2012 Dec; 14(12):1420-8.
    View in: PubMed
    Score: 0.012
  35. Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study. Circ Arrhythm Electrophysiol. 2012 Aug 01; 5(4):626-31.
    View in: PubMed
    Score: 0.012
  36. Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol. 2010 Sep; 21(9):1009-14.
    View in: PubMed
    Score: 0.011
  37. Sport and arrhythmias: summary of an international symposium. Eur J Cardiovasc Prev Rehabil. 2007 Oct; 14(5):707-14.
    View in: PubMed
    Score: 0.009
  38. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001 Apr 24; 103(16):2066-71.
    View in: PubMed
    Score: 0.006
  39. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett. 2000 Feb 25; 280(3):215-9.
    View in: PubMed
    Score: 0.005
  40. Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E. Am J Med Genet. 1999 Oct 15; 88(5):465-8.
    View in: PubMed
    Score: 0.005
  41. No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples. Neurosci Lett. 1999 May 14; 266(3):193-6.
    View in: PubMed
    Score: 0.005
  42. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci Lett. 1998 Aug 14; 252(2):95-8.
    View in: PubMed
    Score: 0.005
  43. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease. Am J Med Genet. 1997 Apr 18; 74(2):192-4.
    View in: PubMed
    Score: 0.004
  44. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol. 1997; 14(3):299-305.
    View in: PubMed
    Score: 0.004
  45. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16; 802:16-26.
    View in: PubMed
    Score: 0.004
  46. Racial differentials in the identification of hypercholesterolemia. J Fam Pract. 1993 Apr; 36(4):425-30.
    View in: PubMed
    Score: 0.003
  47. Barriers to cholesterol testing in a rural community. J Fam Pract. 1991 Jun; 32(6):614-8.
    View in: PubMed
    Score: 0.003
  48. Intraoperative anaphylaxis to latex: an identifiable population at risk. Can J Anaesth. 1990 May; 37(4 Pt 2):S131.
    View in: PubMed
    Score: 0.003
  49. Comparison between the prevalence and treatment of wheezing and coughing in Brampton and Mississauga children. J Clin Epidemiol. 1990; 43(8):765-71.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.